SCHEMBL8003752

SCHEMBL8003752

COc1ccc2c(N)nc(-c3nc(C(C)C)cs3)nc2c1F

nearest known ligand 0.38

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 7/20 0.38
ADORA1 P30542 5/20 0.38
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
APLNR P35414 3/20 0.33
RAD52 P43351 1/20 0.31
TYK2 P29597 1/20 0.30
TP53 P04637 1/20 0.30
MAPT P10636 1/20 0.30
CYP19A1 P11511 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8002647 0.87 APLNR (0.35) ADORA2AADORA1ALDH1A1APLNRTYK2
SCHEMBL8004421 0.87 ADORA2A (0.39) ADORA2AADORA1ALDH1A1APLNRRAD52
SCHEMBL8006887 0.86 ADORA2A (0.36) ADORA2AADORA1MEN1KMT2AALDH1A1
SCHEMBL8003749 0.81 NPC1 (0.37) MEN1KMT2ANPC1ALDH1A1RAB9A
SCHEMBL577207 0.77 APLNR (0.33) MEN1KMT2ANPC1ALDH1A1RAB9A
SCHEMBL8008964 0.77 NPC1 (0.37) MEN1KMT2ANPC1ALDH1A1RAB9A
SCHEMBL314499 0.76 MAPT (0.35) MEN1KMT2ANPC1ALDH1A1RAB9A
SCHEMBL1496441 0.74 ALDH1A1 (0.33) MEN1KMT2ANPC1ALDH1A1RAB9A
SCHEMBL8004418 0.74 CYP1A1 (0.41) ADORA2AADORA1TP53MAPTCYP19A1
SCHEMBL882975 0.74 ALDH1A1 (0.33) ALDH1A1APLNRCYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2250174-B1 MACROCYCLIC SERINE PROTEASE INHIBITORS IDENIX PHARMACEUTICALS INC (US) 2013-08-28 EP disclosed
WO-2009099596-A2 MACROCYCLIC SERINE PROTEASE INHIBITORS IDENIX PHARAMACEUTICALS, INC. (US) 2009-08-13 WO disclosed